ABT vs MDT — Key Metrics

Metric ABT (ABBOTT LABORATORIES) MDT (MEDTRONIC PLC)
Price104.48100.72
Market Cap180.95 Billion128.83 Billion
P/E (TTM)38.8424.63
P/B (Quarterly)3.8752.371
P/S (TTM)3.753.43
Net Profit Margin (TTM)9.713.9
Gross Margin (TTM)56.965.0
ROE (TTM)9.010.6
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

ABBOTT LABORATORIES
vs
 
MEDTRONIC PLC
 
ABBOTT LABORATORIES
vs
 
MEDTRONIC PLC
Performance Comparison
AI Model Recommendation
ABT · ABBOTT LABORATORIES

Underperform

-42
UnderperformOutperform
MDT · MEDTRONIC PLC

Outperform

14
UnderperformOutperform
Recommendation Summary

Stock ABT is projected to underperform the market, stock MDT is projected to outperform the market. Upfront Recommendation: MDT.

Financial Metrics
Prices delayed ~15 min
ABT Metrics MDT
$104.48 Price $100.72
— Market Capitalization —
38.84 Price to Earnings Ratio 24.63
3.75 Price to Sales 3.43
26.78 Price to FCF Ratio 21.01
6.59 Price to Gross Profit 5.28
54.6 Price to R&D 44.15
7.7 Price to Current Assets 5.28

ABT vs MDT at a glance

Abbott Laboratories (ABT) and Medtronic PLC (MDT) are both Medical Devices companies in the Healthcare sector. ABT is the larger, at $181.0 billion in market value against $128.8 billion for MDT, about 1.4 times the size.

On trailing-twelve-month figures, ABT trades at 38.8 times trailing earnings and MDT at 24.6; net profit margins are 9.7% and 13.9%.

The Upfront Investment model currently rates ABT Underperform and MDT Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.